Covered recipient · General Payments record
CHRISTINE J VIDOURIA
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2023
$4,879.27
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.70 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.93 | 6 |
| Nevro Corp. | $105.00 | 3 |
| Pacira Pharmaceuticals Incorporated | $82.68 | 1 |
| Collegium Pharmaceutical, Inc. | $76.25 | 4 |
| Medtronic, Inc. | $42.50 | 1 |
| Abbott Laboratories | $34.34 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.57 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019634351 | CMS |
| Abbott Laboratories | $19.77 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019455417 | CMS |
| AbbVie Inc. | $32.73 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999427991 | CMS |
| AbbVie Inc. | $9.95 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999427997 | CMS |
| AbbVie Inc. | $26.59 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999428003 | CMS |
| AbbVie Inc. | $24.55 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999428009 | CMS |
| AbbVie Inc. | $19.70 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999428017 | CMS |
| AbbVie Inc. | $28.41 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999428023 | CMS |
| Collegium Pharmaceutical, Inc. | $22.13 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987382823 | CMS |
| Collegium Pharmaceutical, Inc. | $20.56 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987382821 | CMS |
| Collegium Pharmaceutical, Inc. | $19.28 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987382819 | CMS |
| Collegium Pharmaceutical, Inc. | $14.28 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987407041 | CMS |
| Medtronic, Inc. | $42.50 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018940083 | CMS |
| Nevro Corp. | $21.07 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051665121 | CMS |
| Nevro Corp. | $31.64 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051665123 | CMS |
| Nevro Corp. | $52.29 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051665225 | CMS |
| Pacira Pharmaceuticals Incorporated | $82.68 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041568875 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.